The SocietyMore than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS communityBecome an ERS member
Chronic pulmonary aspergillosis (CPA) is a severe fungal infection with high morbidity and mortality. Clinical management of CPA is further hampered by limited information about the epidemiology, disease dynamics, sensitivity and specificity of different mycological tests, mechanisms of antifungal resistance, efficient treatment and management strategies. The CPAnet (Chronic Pulmonary Aspergillosis Research Network) Clinical Research Collaboration was launched by the European Respiratory Society (ERS) in 2020 in order to promote a unique platform allowing clinician researchers together with patients and experts in translational research across Europe to develop research ideas and facilitate collaborations geared towards improved clinical management and evidence on CPA.
The CPAnet Steering committee is composed of the CRC chairs, clinician researchers, experts in translational research, early career members and patient representatives.
If you are interested in more information about CPAnet or would like to join the network, please contact firstname.lastname@example.org.